1 / 16

Robert Eckert 1 Giannicola D‘Addario 2 Stephan Schmitz 3

What Do German Office-Based Community Oncologists Expect from ESMO? Results from a 2010 Survey among Members of the Association of Haematologists and Oncologists in Germany (BNHO). Robert Eckert 1 Giannicola D‘Addario 2 Stephan Schmitz 3

bien
Download Presentation

Robert Eckert 1 Giannicola D‘Addario 2 Stephan Schmitz 3

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. What Do German Office-Based Community Oncologists Expect from ESMO?Results from a 2010 Survey among Membersof the Association of Haematologists and Oncologists in Germany (BNHO) Robert Eckert 1 Giannicola D‘Addario 2 Stephan Schmitz 3 1 Onkologische Schwerpunktpraxis, Wendlingen, Germany 2 Onkologie Schaffhausen, Schaffhausen, Switzerland 3 Onkologische Schwerpunktpraxis, Köln, Germany, and Chairman of the Association of Haematologists and Oncologists in Germany (BNHO) 1,2,3 Members of the ESMO Community Oncology Faculty

  2. Community Oncologists We define Community Oncologists as oncologists working mainly outside academic institutions, although they are often involved in clinical research. Data from the U.S. estimate that 80% of cancer patients are being treated outside academic centers by community oncologists. In 2008, ESMO recognized that its members working outside academic institutions may have different needs and wishes from its mainly academically active members, and founded a Community Oncology Faculty as a sub-comittee of its Educational Committee. Over the course of the Community Oncology Faculty meetings it became clear that neither the Faculty members nor ESMO - through its previous surveys – have got clear ideas if there really is a difference among its members in what community oncologists expect from ESMO.

  3. "Berufsverband der Niedergelassenen Hämatologen und Onkologen in Deutschland“ (BNHO): Professional Association of Haematologists and Oncologists in Germany More than 90% of office based haematologists and medical oncologists in Germany are organized in the Berufsverband der niedergelassenen Hämatologen und Onkologen (BNHO), treating 450.000 patients with malignant diseases annually. Therefore, this is a relatively homogenous group of community oncologists that could be easily reached for a survey on their contact with ESMO, and on their needs and wishes towards a European Oncology Society. The questionnaire was distributed (by email on March 5, 2010) to the 533 physicians organized in the BNHO at that time. 160 replies (30%, which we consider sufficiently representative for the group) were received by the end of April 2010 and analyzed. However, these results may not represent German hospital-based community oncologists, or community oncologists in other European countries.

  4. BNHO and ESMO membership Of the 160 responding BNHO members, one half are also ESMO members

  5. Number of Physicians and Intranet / Therapy Planning Tools Of 160 responding BNHO member oncologists, about a quarter each work in single practices or practices with 2, three, or more partners. As to be expected, larger practices more often have an intranet with electronic therapy planning aids (dose calculators, therapy planning aids, printable protocols, or order forms) than smaller practices.

  6. Familiarity with the ESMO Home Page NB: 96% of all responders have internet access at their place of work Of the 80 ESMO members, 94% know the ESMO home page, 6% report not to know it Of the 79 ESMO non-members, 58% know the ESMO home page, 42% report not to know it

  7. Regular Use of ESMO Clinical Recommendations Of the 80 ESMO members, 55% frequently use ESMO‘s Clinical Recommendations, 44% report no or rare usage Of the 79 ESMO non-members, 25% frequently use ESMO‘s Clinical Recommendations, 73% report no or rare usage

  8. Interest in Electronic Tools on the ESMO Home Page • 142 of 160 respondents (89%) are interested in electronic tools on the ESMO homepage. • The following items are of particular interest to them: • Clinical Guidelines (122) • Score Calculators (117) • Therapy Planning Tools / Protocols (68) • Printable Protocols / Pharmacy Order Forms (68) • Dose Calculators (58)

  9. Attendance at ESMO conferences Of the 80 ESMO members, 60% attend ESMO conferences regularly, 33% occasionally and 5% have never attended Of the 79 ESMO non-members, 19% attend ESMO conferences regularly, 57% occasionally and 23% have never attended

  10. Grade of satisfaction with ESMO conferences Of 63 regular ESMO conference attendees, 45% are completely satisfied with the conferences;43% are satisfied with the scientific aspects but miss practice relevance; 5% are satisfied with practice relevance but miss scientific quality; 2% are dissatisfied with ESMO conferences

  11. Grade of satisfaction with ESMO conferences Of 71 occasional ESMO conference attendees, 19% are completely satisfied with the conferences;39% are satisfied with the scientific aspects but miss practice relevance; 8% are satisfied with practice relevance but miss scientific quality; 15% are dissatisfied with ESMO conferences

  12. Wish for Community Oncologists‘ Sessions Of the 134 regular or occasional ESMO conference attendees, 60% would like to have sessions particularly for Community Oncologists;31% see no need for such sessions (No difference among regular or occasional attendees!)

  13. Conclusions I Office-based Community Oncologists treat a substantial proportion of cancer patients in Germany. In this survey among members of the BNHO, we find that: • a substantial proportion of BNHO members are ESMO members; • nearly all BNHO oncologists have internet access at their office; • most ESMO members, but also a majority of non-ESMO menbers know the ESMO homepage; • more than 50% of ESMO members, but only 1 out of 4 non-members use ESMO‘s Clinical Recommendations; • there is a large interest in easily accessible web based tools on the ESMO homepage.

  14. Conclusions II Concerning ESMO conferences, the survey shows that: • 87% of BNHO members regularly or occasionally attend ESMO conferences – ESMO members much more often than non-members; • 45% of regular ESMO conference attendees, but only 19% of occasional attendees, are completely satisfied with the conferences; • 40% of community oncologists attending ESMO conferences regularly or occasionally are satisfied with the scientific content, but miss practice relevance; • 60% of all regular and occasional conference attendees would like to have sessions particularly for Community Oncologists.

  15. Conclusions III This survey, and respondents‘ additional comments, among members of the BNHO clearly show: • an interest in ESMO by German community oncologists; • the need for representation of community oncologists within ESMO; • community oncologists‘ interest in health services research; • a wish for more practice relevance of ESMO conferences whilst maintaining a high scientific standard, possibly through sessions tailored to community oncologists‘ needs and interests; • a great interest in more service provided by ESMO to its members, particularly providing guidelines and online tools.

  16. Conclusions IV • ESMO has a chance to attract more membership among German community oncologists through the implementation of - some of - these topics; • ESMO‘s Community Oncology Faculty will include the suggestions resulting from this German survey in its discussions and work.

More Related